A decisional-support tool to model the impact of regulatory compliance activities in the biomanufacturing industry

Computers and Chemical Engineering

Volumn 28, Issue 5, 2004, Pages 727-735

  Lim, Ai Chye ^a   Zhou, Yuhong ^a   Washbrook, John ^a   Titchener Hooker, Nigel John ^a   Farid, Suzanne ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Biotechnology; Modelling; Process development; QC QA; Simulation

Indexed keywords

BATCH DATA PROCESSING; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEMS; QUALITY ASSURANCE; QUALITY CONTROL; REGULATORY COMPLIANCE; RESOURCE ALLOCATION; SOFTWARE PROTOTYPING; STRATEGIC PLANNING;

BIOPROCESSES; DECISIONAL-SUPPORT TOOL; POOLING STRATEGY;

DRUG PRODUCTS PLANTS;

MEDICAL APPLICATION;

BATCH PROCESS; BIOPROCESS; BIOTECHNOLOGY; COMPUTER PROGRAM; CONFERENCE PAPER; COST; DECISION MAKING; DOCUMENTATION; INDUSTRY; MAMMAL; PERFUSION; QUALITY CONTROL; RESOURCE ALLOCATION;

EID: 1842850971     PISSN: 00981354     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.compchemeng.2004.02.013     Document Type: Conference Paper

References (17)

1. Byrom D. Role and timing of process development for biopharmaceutical manufacture. Pharmaceutical Technology Europe. 12:2000;52-56.
2. Clemento A. New and integrated approaches to successful accelerated drug development. Drug Information Journal. 33:1999;669-710.
3. Doblhoff-Dier, O., & Bliem, R. (1999). Quality control and assurance from the development to the production of biopharmaceuticals. TIBTECH, 17, 266-270.
4. Farid, S. (2001). A decision-support tool for simulating the process and business perspectives of biopharmaceutical manufacture. Ph.D. thesis, University College London.
5. Farid S., Novais J.L., Karri S., Washbrook J., Titchener-Hooker N.J. A tool for modelling strategic decisions in cell culture manufacturing. Biotechnology Progress. 16(5):2000;829-836.
6. Farid, S., Washbrook, J., & Titchener-Hooker, N. J. (2001). In D. Dochain & M. Perrier (Eds.), Decision-support tool for risk analysis in biopharmaceutical manufacture. Proceedings of the 8th international conference on computer applications in biotechnology (CAB8): Modelling and control of biotechnological processes (pp. 167-171). IFAC, EFB.
7. Fisher M.P., Pascucci V.L. Regulatory reflections concerning the state of biotechnology progress. Drug Information Journal. 30:1996;41-46.
8. Geigert J. The challenge of managing quality control/quality assurance for loosely structured and virtual biopharmaceutical companies. Drug Information Journal. 31:1997;97-100.
9. Karri, S., Washbrook, J., & Titchener-Hooker, N. J. (2000). A hierarchical modelling framework for prototyping the biopharmaceutical drug development process. In Proceedings of the AICHE Spring National Meeting.
10. Norris, P. (2001). Seamless process development: Enhancing speed to market and reducing costs, PharmaceuticalVisions, 36-39.
11. Petrides D.P. BioPro designer: An advanced computing environment for modelling and design of integrated biochemical processes. Computers and Chemical Engineering. 18(Suppl.):1994;S621-S625.
12. Pisano, G. P., & Wheelwright, S. C. (1995). High-Tech R&D: The Logic of High-Tech R&D. Harvard Business Reviews, 93-105.
13. Ramsay, B. (2001). Lean compliance in manufacturing. Pharmaceutical Technology Europe, 62-68.
14. Remer, D. S., & Idrovo, J. H. (1991). Cost-estimating factors for biopharmaceutical process equipment. Pharmaceutical Tech. International, 36-42.
15. Sinnott, R. K. (1993). Coulson & Richardson's chemical engineering (Chapter 6). Perganon Press: Oxford, 6.
16. Walsh G. Biopharmaceutical benchmarks. Nature Biotechnology. 18:2000;831-833.
17. Walsh, G., & Murphy, B. (2000). Biopharmaceuticals, an industrial perspective (Chapter 1), Dordrecht: Kluwer Academic Publishers.